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ABSTRACT
The authors describe a peculiar form of Epstein-Barr virus (EBV)-associated T-cell lymphoma in an HIV-positive patient 
presenting an aggressive clinical course. Unlike most other EBV-positive T-cell/natural-killer (NK)-cell lymphomas, the 
disease was characterized by predominant nodal involvement at presentation. T-cell lineage was confirmed by T-cell 
receptor-rearrangement, and neoplastic cells exhibited strong and diffuse CD56 expression. A marked intravascular 
component was detected in the skin, the liver, and the lung parenchyma. This entity was not predicted in the WHO 2008 
classification, but has been recently identified in immunocompromised patients. This case report refers to a middle-aged 
man with AIDS, who presented a 4-month history of weight loss, fever, hepatosplenomegaly, peripheral and deep-chain 
lymphadenopathy. A blood smear showed lymphocytosis with a marked presence of atypia. The outcome was unfavorable 
and the patient could not be treated. The autopsy revealed multivisceral involvement, including lymph nodes, spleen, 
bone marrow, liver, lungs, skin, and kidneys.
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CASE REPORT
A 54-year-old Afro-Brazilian male patient sought 
the emergency unit complaining of right lower limb 
pain, which had been worsening over the past 3 days. 
He also presented a 4-month history of weight loss 
(10 kg) accompanied by weakness, progressive 
lethargy, sporadic fever, and the presence of non-tender 
tumors in the axillary and groin regions. He smoked 
10 packs/year, drank 30-40 g of alcohol daily for more 
than 10 years, used marijuana and cocaine, and had 
unprotected sexual intercourse. Physical examination 
on admission disclosed an ill-looking patient, who was 
hypoactive, drowsy, pale, and dehydrated. Enlarged, 
non-tender lymph nodes, measuring up to 2 cm, 
were palpable in the axillary, cervical, and inguinal 
chains. The cardiac and pulmonary examinations 
were unremarkable; however, the abdomen was 
mildly distended, with tender hepatosplenomegaly. 
The right lower limb showed an asymmetric edema. 
Echo Doppler showed a thrombosis from the right 
common femoral vein until the ipsilateral popliteal 
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vein. Laboratory work up of admission is summarized 
in Table 1.
The peripheral blood film exhibited the presence 
of 23% of large to medium-sized lymphocytes, some 
of them with vacuoles, basophilic cytoplasm, and fine 
chromatin with two to three nucleoli (Figure 1A).
Brain, nasal, and nasopharyngeal computed 
tomography (CT) were normal. Thoracic CT showed 
axillary and mediastinal lymphadenopathy (Figure 2), 
and the abdominal examination showed splenomegaly 
with a probable area of infarction; and retroperitoneal, 
mesenteric, and bilateral inguinal lymphadenopathy 
(Figure 3).
The patient was submitted to a fine-needle 
aspiration biopsy of the left inguinal lymph node, 
which was further excised. The fine-needle aspiration 
cytology showed hypercellular smears with discohesive 
cells, irregularly folded nuclei, scant cytoplasm, 
Table 1. Initial laboratory work-up results
Exam Result RV Exam Result RV
Hemoglobin 11.9 12.3-15.3 g/dL Ionized Ca++ 1.57 < 1.32 nmol/dL
Hematocrit 36.8 36.0-45.0% ALT 53 9-36 IU/L
Leukocytes 12.2 4.4-11.3 × 103/mm3 AST 162 10-31 IU/L
Segmented 36 45-70% TB 0.4 0.3-1.2 mg/dL
Eosinophil 2 1-4% TP 4.9 6-8 g/dL
Basophil 1 Albumin 2.1 3-5 g/dL
Lymphocyte 58% 18-40% AP 109 50-250 IU/L
Atypical Ly ++++ γGT 102 2-30 IU/L
Monocytes 1 2-9% LDH 2670 120-246 IU/L
Platelets 135 150–400 × 103/mm3 CRP 63 < 5 mg/L
INR 1.26 1.0 Anti-HIV Positive
Urea 39 5-25 mg/dL Anti-HCV Negative
Creatinine 0.52 0.4-1.3 mg/dL Anti-HBs/c* Positives
Potassium 4.6 3.5-5.0 mEq/L Syphilis Negative
Sodium 137 136-146 mEq/L Anti-HTLV-1 Negative
*Anti-HBs and anti-HBc; ALT = alanine aminotransferase; AP = alkaline phosphatase; AST = aspartate aminotransferase; 
CRP = C-reactive protein; γGT = gamma-glutamyl transferase; LDH = lactate dehydrogenase; INR = international normal-
ized ratio; TB = total bilirubin; TP = total protein.
Figure 1. A - Photomicrography of peripheral blood film showing a high magnification field with four atypical 
lymphocytes. (Leishman’s staining, 1000X); B - Photomicrography of fine needle aspiration biopsy of the lymph 
node showing discoesive cells, irregularly folded nuclei, scant to moderate cytoplasm and cytoplasmic granules of 
atypical lymphoma cells (May-Grunwald stain, 400x).
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inconspicuous nucleoli, and cytoplasmic granules, 
which were consistent with an aggressive non-Hodgkin 
lymphoma (Figure 1B).
The lymph node excisional biopsy showed diffuse 
and permeative lymphomatous growth with focal 
angiocentrism and areas of necrosis and apoptotic 
bodies. The cells were medium-sized to large, mostly 
monomorphic, but with some anaplastic foci, with 
irregularly folded nuclei, granular chromatin, and 
inconspicuous nucleoli. The cytoplasm was moderate-
to-scant and eosinophilic. Many mitotic figures were 
present (Figure 4). The immunohistochemical panel 
is shown in Table 2. In situ hybridization for Epstein-
Barr virus (EBV) was diffusely positive (Figure 5 and 
Figure 6). These features were consistent with an 
aggressive non-Hodgkin lymphoma, most likely of 
natural killer (NK)/T-cell phenotype and T-cell receptor 
gamma gene rearrangement by polymerase chain 
reaction (PCR) was present and clonal.
The outcome was unfavorable with extensive 
local lymphedema and infection of the surgical site. 
Blood culture isolated Staphylococcus epidermidis in 
the blood sample (one in eight samples) treated with 
oxacillin. However, he remained hypoactive, obtunded, 
and presented multiple organ failure. He died on the 
tenth day of hospitalization.
AUTOPSY
An emaciated male cadaver with an abdominal 
paramedian incision scar was examined. Lower 
l imbs edema was present along with multiple 
pigmented somewhat atrophic bilateral skin lesions. 
Histology showed chronic dermatitis with acanthosis, 
hyperkeratosis, and mild lymphomononuclear 
perivascular inflammation and atypical lymphomatous 
cells (Figure 7A). Deep venous thrombosis was 
identified in the right inguinal and popliteal regions. 
The inguinal surgical incision site drained fibrinous and 
purulent exudate. Microscopic examination revealed an 
abscess with necrotic debris and multiple Gram-positive 
and Gram-negative bacterial colonies. The heart was 
enlarged due to left ventricle hypertrophy (heart 
weight: 596g; mean reference value [mRV]: 327g). The 
Figure 2. Axial CT of the thorax. A - Axillary lymphadenopathy (arrows); B - Mediastinal involvement of lymph 
nodes (arrows).
Figure 3. CT of the abdomen—coronal reformation. A - Splenomegaly with a hypoattenuating peripheral area 
(arrowhead), and periaortic lymphadenopathy; B - Bilateral enlarged lymph nodes in the iliac chain (arrows); 
C - Lymphadenopathy in the groin region (arrows).
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lungs were friable, reddish/purple, and heavy (right 
lung weighed 1244 g; mRV: 450 g; and the left lung 
weighed 675 g; mRV: 375 g), with multiple scattered 
foci of consolidation, which were confirmed as acute 
bronchopneumonia and acute alveolar damage upon 
histological examination. Focal septic emboli were 
detected as well. Enlarged lymph nodes measuring 
up to 4 cm were present in the pulmonary hila and 
around the carina.
Numerous enlarged lymph nodes were present 
mainly in the iliac bifurcation and in the groin. 
Lymphoma cells diffusely infiltrated the spleen and 
bone marrow. Intra or perivascular malignant cells 
were found in the lungs, skin, and liver (Figure 7B-D).
The spleen was winy-colored, enlarged (weighed 
910 g: mRV: 112 g) and hardened. At the subcapsular 
region, friable whitish/yellowish areas were present and 
acute infarction was confirmed on histology (Figure 8).
The liver weighed 2314 g (mRV: 1985 g). The 
pancreas was slightly hardened without focal lesions. 
Alcoholic chronic pancreatitis was diagnosed at 
histology. In the digestive tract, erosions were found 
in the stomach, rectum, and sigmoid.
The kidneys presented subcortical cysts. Focal 
malignant cells could be identified in glomeruli. 
Acute tubular necrosis was evident. Signs of chronic 
Figure 4. Photomicrography of lymph node biopsy. A - Diffuse solid lymphomatous growth (H&E, 100X); 
B - Monomorphic cells with irregularly folded nuclei and granular chromatin (H&E, 200X); C - Focal angiocentric 
pattern (H&E, 400X); D - Many apoptotic bodies and inconspicuous nucleoli (H&E, 400X).
Table 2. Immunohistochemistry panel
Antigen Result Antigen Result
CD20 Negative Bcl-2 Positive
CD3 Positive Bcl-6 Negative
CD5 Negative CD138 Negative
CD4 Negative CD10 Negative
CD8 Negative CD21 Negative
CD56 Positive Granzyme Positive
CD30 Positive Perforin Positive
EMA Negative TCL-1 Negative
ALK Negative Ki67 Positive 99%
EBV(LMP1)* 
(LMP1) Negative
*In situ hybridization for EBER was diffusely positive.
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Figure 5. Photomicrography of lymph node biopsy. A - Negative immunohistochemistry for CD20 (400X); B - Positive 
immunostaining for CD3 (400X); C - Immunostaining for CD30 (400X); D - Diffusely positive in situ hybridization 
for EBV (in blue) (400X).
Figure 6. Photomicrography of lymph node biopsy. A - Positive immunostaining for CD56 (400X); B - Negative 
immunostaining for CD8 (200X); C - Positive immunostaining for granzyme (400X) and D - perforin (200X).
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Figure 7. Systemic infiltration of organs by lymphoma cells: skin (A – arrow pointing to an atypical intravascular 
lymphoma cell; H&E, 400X); lung (B - H&E, 200X); kidney glomerulus (C – arrow pointing to an atypical intracapillary 
lymphoma cell; H&E, 400X); perivascular and periportal lymphomatous infiltration of the liver (D - H&E, 200X).
Figure 8. A - Gross aspect of the enlarged spleen with infarcts. AT microscopy: B - Perivascular and nodular 
lymphomatous infiltration (H&E, 100X); C - An area of infarct (H&E, 100X); D - Lymphoma with some anaplastic 
cells (H&E, 400X).
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systemic hypertension were present in the kidneys 
and brain. Autopsy also diagnosed acute adrenalitis 
with cytomegalovirus inclusions confirmed by 
immunohistochemistry.
DISCUSSION
Historically, NK cells were described in 1975 by 
both the Kiessling group and the Herberman group.1-5 
Later, in 1987, a population of T-cells that shared some 
features with NK cells, such as cytotoxic activity and 
immunophenotype positivity for NK markers, was 
described. Recently, this subset of T-cells has been 
called NKT cells (also known as NK-like T-cells).6,7 The 
term NK-like T-cells was initially used to refer to any 
T-cell that expressed cell surface antigens associated 
with the NK-cell lineage. NKT cells are a small 
population of thymus-derived T-cell that are restricted 
by the CD1d histocompatibility complex protein class 
I-like (MHC-I) molecule, expressing semi-invariant T-cell 
receptor (TCR) that confers a specificity for glycolipid 
antigens. However, the classification of NKT cells is 
problematic because it does not define a T-cell lineage 
with unique phenotypical or functional attributes, 
but they represent distinct lineages of T-cells that can 
express NK-cell antigens.8
NK cells and their functions are at the interface 
between innate and adaptive immunity. The innate 
immune system shows characteristics of recognition 
of molecular patterns and rapid response, and there 
is no need for clonal expansion. But, the boundaries 
between lymphocytes of the innate and adaptive 
immune system are blurred, since some innate 
lymphocytes can rearrange clonal antigen receptor loci 
and at the same time show the same characteristics of 
the innate immune system. Between T lymphocytes, 
there are αβ TCR-expressing T-cells of which the TCR 
does not recognize MHC/peptide complexes. They are 
called invariant NKT cells (iNKT) and T-cells expressing 
γδ TCRs, both of which are related to the CD1d restrict 
molecule and the CD56 positive immunophenotype.8,9
An overlap between a subpopulation of the T-cell 
and the NK-cell antigen expression, function, and 
patterns of disease does exist, probably because both 
arise from the same bi-potential NK/T precursors, being 
ontogenetically similar.1,10 NK cells and subtypes of 
T-cells are considered as cytotoxic cells, which contain 
cytotoxic granule proteins such as TIA-1, granzyme, 
and perforin in their cytoplasm. Moreover, there is also 
a subset of cytotoxic T-cells that express NK-associated 
antigens (such as CD56) representing the NKT cells.10-12
This complex network of the immune system 
is reflected in the histopathologic and phenotypic 
heterogeneity within distinct lymphoma entities, 
with overlapping features between different entities, 
especially among T-cell and NK-cell lymphomas.13 Most 
extranodal lymphomas arise from cytotoxic cells, since 
these cells are located mainly at extranodal sites, such 
as the splenic red pulp, gastrointestinal tract, skin, and 
other epithelial sites, with primary nodal involvement 
being rare.11,12
This case report illustrates how challenging the 
classification of T-cell and NK-cell lymphomas is. 
Herein, we report a rare case of an HIV-related T-cell/
NK-cell disseminated lymphoma with prevailing nodal 
involvement, NK cell immunophenotype and clonal 
TCR gene rearrangement.
Despite the rarity of NK-cell neoplasms, the most 
common and well-characterized neoplasm of this 
cell lineage is the extranodal NK/T-cell lymphoma, 
nasal type (ENKTCL).11,14 By definition, ENKTCL is a 
predominantly extranodal lymphoma characterized 
by vascular damage and destruction, prominent 
necrosis, cytotoxic phenotype, and is associated with 
EBV. It is designated “NK/T” because, while most 
cases appear to be genuinely NK-cell neoplasms, some 
show a cytotoxic T-cell phenotype and a clonal TCR 
rearrangement.15 These criteria were better established 
in 1994 by the Hong Kong workshop sponsored by the 
Society of Hematopathology, later supported by the 
data of Emile et al.16-19 Morphologically, the disease is 
characterized by a polymorphic infiltrate, consisting 
of atypical cells with a broad cytological spectrum, 
which include small, medium-sized, or large atypical 
cells, with a mixture of inflammatory cells, which are 
frequently associated with zonal pattern necrosis and 
admixed apoptotic bodies.15,18
ENKTCL is more prevalent in Asian and native 
populations of Mexico, Central America, and South 
America, whereas it is uncommon in North America 
and Europe. It occurs most often in adults (median age 
ranges from 49 to 53 years) and is more prevalent in 
males.15,20-22 According to the site of origin, ENKTCL 
can be divided into two major subtypes: nasal and 
extranasal (often referred to as extranasal NK/T 
cell lymphomas).15,23 The nasal subtype is the most 
frequent and affects the upper aerodigestive tract, 
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with the nasal cavity being the prototypic site of 
involvement. Extranasal NKTCL is frequently detected 
at an advanced stage, shows the same histopathology 
and immunophenotipic characteristics of the nasal 
NKTCL, but involves other extranodal sites, such as 
skin, soft tissue, gastrointestinal tract, and testis, 
usually without lymphadenopathy nor any apparent 
nasal involvement.15,23 Bone marrow involvement, at 
the time of diagnosis, is uncommon in nasal (< 3.5%) 
and extranasal (< 7%) NKTCL.20
Until today, only a few cases of extranasal 
NKTCL with primary lymph node disease have been 
described.21,24-27 A high frequency of monoclonal 
TCR gene rearrangement in the nodal NKTCL series 
was observed, showing that, despite the similar 
immunophenotype, some are derived from cytotoxic 
T-cells.20,26 Nodal NKTCLs involve the cervical lymph 
nodes, present similar histology and phenotype of 
extranodal NKTCL and have a poor prognosis (less than 
12 months’ survival).20
Another NK-cell neoplasm considered in the 
differential diagnosis, of the case reported herein, was 
the aggressive NK cell leukemia/lymphoma (ANKL). 
Except for the higher positivity of CD16 in ANKL, 
NKTCL and ANKL share an identical immunophenotypic 
profile; namely, CD2+, CD3ε+ (cytoplasmic), CD56+, 
CD4-, CD5-, TIA-1+, granzyme+, perforine+, a 
strong association with EBV by in situ hybridization 
for EBER and germline configuration of the TCR 
gene.15 However, ANKL shows some distinguishing 
features: involvement of young-aged patients, 
(from teenager to middle-aged: mean = 39 years), 
lack of gender predominance, and the presence of 
tumoral cells in the peripheral blood, as well as bone 
marrow infiltration—albeit minimal in some cases. 
The cutaneous involvement is uncommon and nodal 
disease is more frequently observed. Morphology 
is of monotonous-appearing; the involved tissues 
are usually dense, permeative, with medium-sized 
lymphoid cells with round nuclear contour. Prominent 
apoptosis and angioinvasive-angiodestructive growth 
pattern also can be seen.15,24,28 ANKL presents a fatal 
clinical course; most patients die within days-to-
weeks after presentation (median survival of 58 days). 
Distinguishing ANKL from advanced systemic NKTCL 
is not an easy task because of the discrepancy of a 
high number of neoplastic cells in the peripheral blood 
and poor bone marrow infiltration. Patients with nasal 
NKTCL rarely develop features of ANKL.15,24,29-31
The case report herein seems to be similar 
to the rare cases reported on the lymphoma 
workshop of the XVIth meeting of the European 
Association for Haematopathology and the Society 
for Hematopathology (EAHP lymphoma workshop).32 
The workshop encountered four cases of EBV-
positive T-cell lymphoma that did not conform to 
NKTCL as classically defined. The cases were relatively 
monomorphic and all had lymph node involvement at 
presentation. Interestingly, the cases were associated 
with immunodeficiency, were HIV-associated, and 
presented a marked intravascular component (both 
features present in the case herein reported), and post-
transplant or advanced age related. These observations 
confirm that not all EBV-positive T-cell lymphomas 
should be classified as NKTCL, but whether they 
represent a distinct entity remains to be determined. 
(The term “nodal T-cell/NK-cell lymphoma” was 
proposed to separate these cases.32)
Interestingly, one of the first series of NKT cells 
lymphoma in literature, described by Macon et al.,7 
showed EBV-associated disease, in an advanced stage, 
with a median survival less than 6 months and a high 
frequency of chronically immunosuppressed patients 
(four out of six patients). The authors suggested that 
NK-like T-cell lymphomas should be included in the 
differential diagnosis of T-cell proliferations developing 
in immunosuppressed patients.
Our case report had many similarities with ANKL, 
such as monomorphic morphology, bone marrow and 
peripheral blood involvement, and nodal presentation. 
However, the patient was out of the usual age range 
for this neoplasia, was HIV-associated, and presented 
a clonal TCR rearrangement. To the best of our 
knowledge, there is no case of ANKL related to HIV in 
the English literature.
Most non-Hodgkin lymphomas that have 
developed in HIV patients showed B-cell phenotypes, 
such as Burkitt lymphoma, primary effusion lymphoma, 
plasmoblastic lymphoma of the oral cavity, and 
multicentric Castleman disease. HIV patients with 
lymphoma often present extranodal disease, most 
frequently involving the gastrointestinal tract, the 
central nervous system, the bone marrow, and the 
liver.15 There are very few reported cases of NK/T-cell 
lymphoma associated with EBV in an HIV patient.33-35 
Canioni et al.36 reported the first case of NKTCL in an 
HIV patient in 2001. NKTCL cases in HIV have varied 
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with respect to immunophenotype, sites of disease, 
and clinical presentation.36 The primary sites of disease 
of NKTCL related to HIV patients include nasopharynx, 
tonsil, parotid gland, lung/mediastinum, colon, liver, 
and lymph node. The majority of patients were men 
(median age of 42 years), with low CD4 counts (< 200/
dL). The prognosis of NKTCL in HIV-related patients is 
very poor, usually with less than 1 month of survival.33-35
This case report illustrates the challenging 
diagnosis and classification of NK-cell neoplasms, 
particularly in the HIV-infected patient. Moreover, 
the diagnosis of NK/T-cell neoplasms is complicated 
by the significant phenotype overlap between NK 
cells and cytotoxic T-cells, and the lack of a clonal 
marker in NK cell neoplasms. Despite the overlap 
of this case report between both NKTCL and ANKL, 
this case most probably represents the nodal T-cell/
NK-cell lymphoma HIV-related proposed by the EAHP 
lymphoma workshop.32
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